Rare Metabolic Causes of Osteomalacia

Osteomalacia refers to softening of the bones in adults due to defective bone mineralization. While vitamin D deficiency and chronic kidney disease are common culprits, a handful of rare metabolic disorders can also lead to osteomalacia. Recognizing these uncommon causes of osteomalacia is key to accurate diagnosis and targeted treatment.

Understanding Osteomalacia

• Normal bone relies on a balance of calcium, phosphate and vitamin D.
• Disruption in any step—from vitamin D activation to phosphate handling—can weaken bone.
• Symptoms often develop gradually: bone pain, muscle weakness and an increased fracture risk.

Why Focus on Rare Causes of Osteomalacia?

• Patients who do not improve with standard treatments (vitamin D, calcium supplements) may have an underlying metabolic disorder.
• Early identification prevents complications and guides specific therapies.
• Genetic counseling may be necessary for inherited forms.

---

Major Rare Metabolic Causes of Osteomalacia

1. Tumor-Induced Osteomalacia (TIO)

• Mechanism: Small mesenchymal tumors secrete excess fibroblast growth factor 23 (FGF23).
• Effect: FGF23 reduces phosphate reabsorption in the kidney and lowers active vitamin D levels.
• Clinical clues:
  • Adults with unexplained bone pain, muscle weakness
  • Hypophosphatemia, elevated alkaline phosphatase, low or inappropriately normal 1,25-dihydroxyvitamin D
• Diagnosis: Measure FGF23, functional imaging (e.g., octreotide scan, PET).
• Treatment: Surgical removal of the tumor; if not possible, phosphate supplements plus activated vitamin D analogs (calcitriol).

2. Hypophosphatasia

• Mechanism: Mutations in the ALPL gene reduce tissue-nonspecific alkaline phosphatase (TNSALP) activity.
• Effect: Accumulation of pyrophosphate inhibits mineralization.
• Clinical clues:
  • History may include early dental loss, stress fractures, bone pain
  • Low serum alkaline phosphatase (a hallmark)
• Diagnosis: Genetic testing; elevated substrates (phosphoethanolamine) in blood or urine.
• Treatment: Asfotase alfa (enzyme replacement therapy) in severe cases; supportive care (analgesics, physical therapy).

3. Proximal Renal Tubular Acidosis (Fanconi Syndrome)

• Mechanism: Disruption of proximal tubule causes loss of phosphate, bicarbonate, glucose, amino acids.
• Effect: Chronic phosphaturia leads to inadequate bone mineralization.
• Clinical clues:
  • Polyuria, dehydration, growth failure (children), rickets/osteomalacia
  • Metabolic acidosis, hypophosphatemia, glycosuria
• Causes:
  • Inherited (e.g., cystinosis, Wilson disease)
  • Acquired (e.g., certain medications, heavy metals)
• Diagnosis: Blood gases, electrolytes, urine studies.
• Treatment:
  • Correct acidosis (oral bicarbonate or citrate)
  • Phosphate supplements, activated vitamin D
  • Address underlying cause (e.g., stop offending drug, chelation for heavy metals).

4. Vitamin D-Dependent Rickets/Osteomalacia Type I

• Mechanism: Deficiency of 1α-hydroxylase (CYP27B1) prevents conversion of 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D.
• Effect: Low active vitamin D despite normal 25-hydroxy levels.
• Clinical clues:
  • Symptoms of bone pain and muscle weakness
  • Low or undetectable 1,25-dihydroxyvitamin D, normal 25-hydroxyvitamin D
• Diagnosis: Enzyme assay, genetic testing.
• Treatment: Lifelong calcitriol (active vitamin D) and calcium supplements.

5. Vitamin D-Dependent Rickets/Osteomalacia Type II

• Mechanism: Mutations in the vitamin D receptor (VDR) cause resistance to 1,25-dihydroxyvitamin D.
• Effect: Poor response to active vitamin D at cellular level.
• Clinical clues:
  • Alopecia (in some cases), growth failure (children), bone pain
  • High 1,25-dihydroxyvitamin D despite hypocalcemia
• Diagnosis: Genetic testing for VDR mutations.
• Treatment: High doses of calcitriol, oral calcium; some may require intravenous calcium initially.

6. Hereditary Hypophosphatemic Rickets (Adult Presentation)

• Subtypes include:
  • X-linked hypophosphatemia (PHEX mutations)
  • Autosomal dominant hypophosphatemic rickets (FGF23 mutations)
• Mechanism: Excess FGF23 or PHEX deficiency leads to renal phosphate wasting.
• Effect: Chronic hypophosphatemia, low active vitamin D.
• Clinical clues:
  • Family history of rickets/osteomalacia
  • Low serum phosphate, elevated alkaline phosphatase
• Diagnosis: Genetic testing, FGF23 levels.
• Treatment:
  • Burosumab (anti-FGF23 antibody) for X-linked form
  • Phosphate supplements and calcitriol for others.

7. Other Rare Metabolic/Genetic Disorders

• Fanconi–Bickel syndrome: GLUT2 mutation causing glycogen storage, proximal tubular dysfunction.
• Lowe syndrome: OCRL gene mutation with Fanconi-like features plus cataracts, intellectual disability.
• Cystinosis: Lysosomal cystine accumulation leads to Fanconi syndrome.
• Wilson disease: Copper buildup can damage proximal tubules.
• Heavy-metal intoxication: Lead and cadmium impair vitamin D metabolism and tubular function.

---

How These Disorders Present

Patients with rare causes of osteomalacia often share symptoms with more common forms, but with additional “red flags”:

• Persistent bone pain and muscle weakness despite standard vitamin D and calcium therapy
• Fractures from minimal trauma (stress fractures)
• Laboratory findings that don’t match simple vitamin D deficiency (e.g., low alkaline phosphatase in hypophosphatasia; normal 25-hydroxyvitamin D in type I vitamin D–dependent forms)
• Family history of similar bone disease, early tooth loss or growth problems (in inherited forms)
• Signs of proximal tubular dysfunction: polyuria, dehydration, growth failure, metabolic acidosis.

---

Diagnosing Rare Causes of Osteomalacia

A stepwise approach helps uncover an uncommon metabolic or genetic origin:

1. Basic labs:
   • Serum calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D, PTH
   • Kidney function, acid–base status
2. Targeted tests:
   • 1,25-dihydroxyvitamin D, FGF23, alkaline phosphatase isoforms
   • Urine studies (phosphate excretion, amino acids, glucose)
3. Genetic analysis:
   • When lab patterns point to enzyme defects or receptor mutations
4. Imaging:
   • Bone-scan or dual-energy X-ray absorptiometry (DEXA) for fracture risk
   • Functional tumor localization (for suspected TIO)
5. Referral:
   • Endocrinologist, nephrologist or geneticist for complex cases

---

Treatment Principles

Even among rare causes of osteomalacia, general strategies apply:

• Correct underlying defect whenever possible
• Replace missing or inactive hormones
  • Calcitriol for vitamin D-dependent forms
  • Burosumab for certain FGF23-mediated disorders
• Supplement minerals
  • Oral phosphate for hypophosphatemia
  • Calcium salts if needed
• Enzyme replacement
  • Asfotase alfa in hypophosphatasia
• Manage complications
  • Fracture prevention, physical therapy
  • Monitor for nephrocalcinosis with high-dose vitamin D or phosphate therapy

Most patients require lifelong follow-up, periodic lab checks and dose adjustments.

---

When to Seek Medical Advice

If you have persistent bone pain, muscle weakness or fractures that don’t respond to standard vitamin D and calcium supplements, it may be time to look beyond the usual causes. For a free, online symptom check, using the doctor approved Ubie Symptom Checker, click here: free, online symptom check, using the doctor approved Ubie Symptom Checker.

Always speak to a doctor about any concerning symptoms, especially if they could signal a serious or life-threatening condition. Early evaluation by a healthcare professional—ideally an endocrinologist or nephrologist—can ensure the correct diagnosis and targeted treatment plan.

---

Key Takeaways

• Rare metabolic disorders account for a small but significant share of adult osteomalacia cases.
• Look for atypical lab values (low alkaline phosphatase, normal 25-hydroxyvitamin D with symptoms) and signs of tubular dysfunction or FGF23 excess.
• Genetic testing and advanced imaging often confirm the diagnosis.
• Treatment is tailored: vitamin D analogs, phosphate, enzyme replacement or targeted antibodies.
• Lifelong follow-up is essential to monitor therapy response and prevent complications.

If you suspect you have a rare cause of osteomalacia or are not improving with standard therapy, consult your doctor for specialized testing and management.